I asked him about Zenith, if he had a dual role....and he indicated that he does play a role with Zenith as well, although he didn't seem to define it clearly.  I told him of my conversation with DM at B&B an how I was left with the impressiont that Zenith would be bought out in another 2 or 3 months.  

He didn't comment definitively at all about the prospects of a buyout....but  simply said that any successes achieved by Zenith (whether they be clinical, partnerships or a buyout), that they would reflect on Resverlogix as well.